Cart
sales@molnova.com
NIC3
CAS No. 494830-67-0
NIC3 ( —— )
Catalog No. M26332 CAS No. 494830-67-0
NIC3 is a selective nucleus accumbens-associated protein-1 (NAC1) inhibitor, with anti-cancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 177 | In Stock |
|
| 50MG | 282 | In Stock |
|
| 100MG | 484 | In Stock |
|
| 200MG | 677 | In Stock |
|
| 500MG | 1035 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNIC3
-
NoteResearch use only, not for human use.
-
Brief DescriptionNIC3 is a selective nucleus accumbens-associated protein-1 (NAC1) inhibitor, with anti-cancer activity.
-
DescriptionNIC3 is a selective nucleus accumbens-associated protein-1 (NAC1) inhibitor, with anti-cancer activity.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number494830-67-0
-
Formula Weight440.6
-
Molecular FormulaC26H36N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)C1=CC=C(OCC(NCCNC(COC2=CC=C(C(C)(C)C)C=C2)=O)=O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
-
ML-211
ML-211 is a carbamate-based dual inhibitor of LYPLA1 (IC50?= 17 nM) and the related LYPLA2 (IC50?= 30 nM).
-
Ginsenoside F4
Ginsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.
-
α-Factor Mating Pher...
The alpha factor pheromone arrests yeast in the G1 phase of their cell cycle. Alpha Factor Mating Pheromone induces the expression of mating genes, changes in nuclear architecture, and polarzes growth toward the mating partner.
